OtherClinical Investigations (Human)
Open Access
FAPI-74 PET/CT Using Either 18F-AlF or Cold-kit 68Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients
Frederik Giesel, Sebastian Adeberg, Mustafa Syed, Thomas Lindner, Luis David Jimenez, Eleni Mavriopoulou, Fabian Staudinger, Eric Tonndorf-Martini, Sebastian Regnery, Stefan Rieken, Rami ElShafie, Manuel Röhrich, Paul Flechsig, Andreas Kluge, Annette Altmann, Juergen Debus, Uwe A. Haberkorn and Clemens Kratochwil
Journal of Nuclear Medicine September 2020, jnumed.120.245084; DOI: https://doi.org/10.2967/jnumed.120.245084
Frederik Giesel
1 University Hospital Heidelberg, Germany;
Sebastian Adeberg
2 Heidelberg University, Germany;
Mustafa Syed
1 University Hospital Heidelberg, Germany;
Thomas Lindner
1 University Hospital Heidelberg, Germany;
Luis David Jimenez
3 ABX CRO, Germany;
Eleni Mavriopoulou
1 University Hospital Heidelberg, Germany;
Fabian Staudinger
1 University Hospital Heidelberg, Germany;
Eric Tonndorf-Martini
1 University Hospital Heidelberg, Germany;
Sebastian Regnery
1 University Hospital Heidelberg, Germany;
Stefan Rieken
1 University Hospital Heidelberg, Germany;
Rami ElShafie
1 University Hospital Heidelberg, Germany;
Manuel Röhrich
1 University Hospital Heidelberg, Germany;
Paul Flechsig
1 University Hospital Heidelberg, Germany;
Andreas Kluge
3 ABX CRO, Germany;
Annette Altmann
1 University Hospital Heidelberg, Germany;
Juergen Debus
1 University Hospital Heidelberg, Germany;
Uwe A. Haberkorn
1 University Hospital Heidelberg, Germany;
Clemens Kratochwil
4 University Hospital of Heidelberg, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
FAPI-74 PET/CT Using Either 18F-AlF or Cold-kit 68Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients
Frederik Giesel, Sebastian Adeberg, Mustafa Syed, Thomas Lindner, Luis David Jimenez, Eleni Mavriopoulou, Fabian Staudinger, Eric Tonndorf-Martini, Sebastian Regnery, Stefan Rieken, Rami ElShafie, Manuel Röhrich, Paul Flechsig, Andreas Kluge, Annette Altmann, Juergen Debus, Uwe A. Haberkorn, Clemens Kratochwil
Journal of Nuclear Medicine Sep 2020, jnumed.120.245084; DOI: 10.2967/jnumed.120.245084
FAPI-74 PET/CT Using Either 18F-AlF or Cold-kit 68Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients
Frederik Giesel, Sebastian Adeberg, Mustafa Syed, Thomas Lindner, Luis David Jimenez, Eleni Mavriopoulou, Fabian Staudinger, Eric Tonndorf-Martini, Sebastian Regnery, Stefan Rieken, Rami ElShafie, Manuel Röhrich, Paul Flechsig, Andreas Kluge, Annette Altmann, Juergen Debus, Uwe A. Haberkorn, Clemens Kratochwil
Journal of Nuclear Medicine Sep 2020, jnumed.120.245084; DOI: 10.2967/jnumed.120.245084
Jump to section
Related Articles
Cited By...
- A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers
- Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG-Negative Pulmonary Lesions
- 68Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression
- Fibroblast Activation Protein-Targeted PET/CT with 18F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18F-FDG PET/CT
- Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
- Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
- Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
- Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
- Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
- Biodistribution, Dosimetry, and Pharmacokinetics of 68Ga-CBP8: A Type I Collagen-Targeted PET Probe
- Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy